Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats

Acute kidney injury (AKI), a clinical syndrome, is a sudden onset of kidney failure that severely affects the kidney tubules. One potential treatment is dexmedetomidine (DEX), a highly selective α2-adrenoreceptor agonist that is used as an anesthetic adjuvant. It also has anti-inflammatory, neuropro...

Full description

Saved in:
Bibliographic Details
Main Authors: Naren Bao, Di Dai
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2020/2120971
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409597875421184
author Naren Bao
Di Dai
author_facet Naren Bao
Di Dai
author_sort Naren Bao
collection DOAJ
description Acute kidney injury (AKI), a clinical syndrome, is a sudden onset of kidney failure that severely affects the kidney tubules. One potential treatment is dexmedetomidine (DEX), a highly selective α2-adrenoreceptor agonist that is used as an anesthetic adjuvant. It also has anti-inflammatory, neuroprotective, and sympatholytic qualities. The aim of this study was to establish whether DEX also offers protection against ischemia and reperfusion- (I/R-) induced AKI in rats. An intraperitoneal injection of DEX (25 μg/kg) was administered 30 min prior to the induction of I/R. The results indicate that in the I/R rats, DEX played a protective role by reducing the damage to the tubules and maintaining renal function. Furthermore, in response to I/R, the DEX treatment reduced the mRNA expression of TNF-α, IL-1β, IL-6, and MCP-1 in the kidney tissues and the serum levels of TNF-α, IL-1β, IL-6, and MCP-1. DEX also reduced the levels of oxidative stress and apoptosis in the tubular cells. These results indicate that in response to I/R kidney injury, DEX plays a protective role by inhibiting inflammation and tubular cell apoptosis, reducing the production of reactive oxygen species, and promoting renal function.
format Article
id doaj-art-758fb9253c124f43b8c93639012d42e4
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-758fb9253c124f43b8c93639012d42e42025-08-20T03:35:27ZengWileyMediators of Inflammation0962-93511466-18612020-01-01202010.1155/2020/21209712120971Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in RatsNaren Bao0Di Dai1Department of Anesthesiology, The First Hospital of China Medical University, 155 Nanjing North Street, Shenyang, ChinaDepartment of Laboratory Medicine, The First Hospital of China Medical University, 155 Nanjing North Street, Shenyang, ChinaAcute kidney injury (AKI), a clinical syndrome, is a sudden onset of kidney failure that severely affects the kidney tubules. One potential treatment is dexmedetomidine (DEX), a highly selective α2-adrenoreceptor agonist that is used as an anesthetic adjuvant. It also has anti-inflammatory, neuroprotective, and sympatholytic qualities. The aim of this study was to establish whether DEX also offers protection against ischemia and reperfusion- (I/R-) induced AKI in rats. An intraperitoneal injection of DEX (25 μg/kg) was administered 30 min prior to the induction of I/R. The results indicate that in the I/R rats, DEX played a protective role by reducing the damage to the tubules and maintaining renal function. Furthermore, in response to I/R, the DEX treatment reduced the mRNA expression of TNF-α, IL-1β, IL-6, and MCP-1 in the kidney tissues and the serum levels of TNF-α, IL-1β, IL-6, and MCP-1. DEX also reduced the levels of oxidative stress and apoptosis in the tubular cells. These results indicate that in response to I/R kidney injury, DEX plays a protective role by inhibiting inflammation and tubular cell apoptosis, reducing the production of reactive oxygen species, and promoting renal function.http://dx.doi.org/10.1155/2020/2120971
spellingShingle Naren Bao
Di Dai
Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
Mediators of Inflammation
title Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
title_full Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
title_fullStr Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
title_full_unstemmed Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
title_short Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
title_sort dexmedetomidine protects against ischemia and reperfusion induced kidney injury in rats
url http://dx.doi.org/10.1155/2020/2120971
work_keys_str_mv AT narenbao dexmedetomidineprotectsagainstischemiaandreperfusioninducedkidneyinjuryinrats
AT didai dexmedetomidineprotectsagainstischemiaandreperfusioninducedkidneyinjuryinrats